GAITHERSBURG, Md. (AP) _ Novavax Inc. (NVAX) on Thursday reported a loss of $322.4 million in its third quarter.

On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $4.31.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $4.04 per share.

The vaccine maker posted revenue of $178.8 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $306.8 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVAX at https://www.zacks.com/ap/NVAX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News